LLM Agent Swarm for Hypothesis-Driven Drug Discovery
- URL: http://arxiv.org/abs/2504.17967v1
- Date: Thu, 24 Apr 2025 22:27:50 GMT
- Title: LLM Agent Swarm for Hypothesis-Driven Drug Discovery
- Authors: Kevin Song, Andrew Trotter, Jake Y. Chen,
- Abstract summary: PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds.<n>By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
- Score: 2.7036595757881323
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Drug discovery remains a formidable challenge: more than 90 percent of candidate molecules fail in clinical evaluation, and development costs often exceed one billion dollars per approved therapy. Disparate data streams, from genomics and transcriptomics to chemical libraries and clinical records, hinder coherent mechanistic insight and slow progress. Meanwhile, large language models excel at reasoning and tool integration but lack the modular specialization and iterative memory required for regulated, hypothesis-driven workflows. We introduce PharmaSwarm, a unified multi-agent framework that orchestrates specialized LLM "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds. Each agent accesses dedicated functionality--automated genomic and expression analysis; a curated biomedical knowledge graph; pathway enrichment and network simulation; interpretable binding affinity prediction--while a central Evaluator LLM continuously ranks proposals by biological plausibility, novelty, in silico efficacy, and safety. A shared memory layer captures validated insights and fine-tunes underlying submodels over time, yielding a self-improving system. Deployable on low-code platforms or Kubernetes-based microservices, PharmaSwarm supports literature-driven discovery, omics-guided target identification, and market-informed repurposing. We also describe a rigorous four-tier validation pipeline spanning retrospective benchmarking, independent computational assays, experimental testing, and expert user studies to ensure transparency, reproducibility, and real-world impact. By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
Related papers
- m-KAILIN: Knowledge-Driven Agentic Scientific Corpus Distillation Framework for Biomedical Large Language Models Training [8.238980609871042]
We propose a knowledge-driven, multi-agent framework for scientific corpus distillation tailored for biomedical training.
Our approach is a collaborative multi-agent architecture, where specialized agents, each guided by the Medical Subject Headings (MeSH) hierarchy, work in concert to autonomously extract, synthesize, and self-evaluate high-quality data.
arXiv Detail & Related papers (2025-04-28T08:18:24Z) - PharmAgents: Building a Virtual Pharma with Large Language Model Agents [19.589707628042422]
We introduce PharmAgents, a virtual pharmaceutical ecosystem driven by multi-agent collaboration.<n>The system integrates explainable, LLM-driven agents equipped with specialized machine learning models and computational tools.<n>It identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility.
arXiv Detail & Related papers (2025-03-28T06:02:53Z) - Chemical knowledge-informed framework for privacy-aware retrosynthesis learning [60.93245342663455]
Current machine learning-based retrosynthesis gathers reaction data from multiple sources into one single edge to train prediction models.
This paradigm poses considerable privacy risks as it necessitates broad data availability across organizational boundaries.
In the present study, we introduce the chemical knowledge-informed framework (CKIF), a privacy-preserving approach for learning retrosynthesis models.
arXiv Detail & Related papers (2025-02-26T13:13:24Z) - Representation Learning of Lab Values via Masked AutoEncoder [2.785172582119726]
We propose Lab-MAE, a transformer-based masked autoencoder framework for imputation of sequential lab values.<n> Empirical evaluation on the MIMIC-IV dataset demonstrates that Lab-MAE significantly outperforms the state-of-the-art baselines.<n>Lab-MAE achieves equitable performance across demographic groups of patients, advancing fairness in clinical predictions.
arXiv Detail & Related papers (2025-01-05T20:26:49Z) - Causal Representation Learning from Multimodal Biomedical Observations [57.00712157758845]
We develop flexible identification conditions for multimodal data and principled methods to facilitate the understanding of biomedical datasets.<n>Key theoretical contribution is the structural sparsity of causal connections between modalities.<n>Results on a real-world human phenotype dataset are consistent with established biomedical research.
arXiv Detail & Related papers (2024-11-10T16:40:27Z) - DrugAgent: Multi-Agent Large Language Model-Based Reasoning for Drug-Target Interaction Prediction [8.98329812378801]
DrugAgent is a multi-agent system for drug-target interaction prediction.<n>It combines multiple specialized perspectives with transparent reasoning.<n>Our approach provides detailed, human-interpretable reasoning for each prediction.
arXiv Detail & Related papers (2024-08-23T21:24:59Z) - Explainable Biomedical Hypothesis Generation via Retrieval Augmented Generation enabled Large Language Models [46.05020842978823]
Large Language Models (LLMs) have emerged as powerful tools to navigate this complex data landscape.
RAGGED is a comprehensive workflow designed to support investigators with knowledge integration and hypothesis generation.
arXiv Detail & Related papers (2024-07-17T07:44:18Z) - BioDiscoveryAgent: An AI Agent for Designing Genetic Perturbation Experiments [112.25067497985447]
We introduce BioDiscoveryAgent, an agent that designs new experiments, reasons about their outcomes, and efficiently navigates the hypothesis space to reach desired solutions.<n>BioDiscoveryAgent can uniquely design new experiments without the need to train a machine learning model.<n>It achieves an average of 21% improvement in predicting relevant genetic perturbations across six datasets.
arXiv Detail & Related papers (2024-05-27T19:57:17Z) - Self-Verification Improves Few-Shot Clinical Information Extraction [73.6905567014859]
Large language models (LLMs) have shown the potential to accelerate clinical curation via few-shot in-context learning.
They still struggle with issues regarding accuracy and interpretability, especially in mission-critical domains such as health.
Here, we explore a general mitigation framework using self-verification, which leverages the LLM to provide provenance for its own extraction and check its own outputs.
arXiv Detail & Related papers (2023-05-30T22:05:11Z) - Towards an Automatic Analysis of CHO-K1 Suspension Growth in
Microfluidic Single-cell Cultivation [63.94623495501023]
We propose a novel Machine Learning architecture, which allows us to infuse a neural deep network with human-powered abstraction on the level of data.
Specifically, we train a generative model simultaneously on natural and synthetic data, so that it learns a shared representation, from which a target variable, such as the cell count, can be reliably estimated.
arXiv Detail & Related papers (2020-10-20T08:36:51Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.